Stock THER THERALINK TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Market Closed - OTC Markets
Other stock markets
 09:58:55 05/06/2024 pm IST 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Theralink Technologies, Inc. 0.00% -93.33%
07/05 IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc. CI
06/05 Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction. CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.
Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Theralink Technologies, Inc. Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute?s Molecular Tumor Board
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
Theralink Technologies, Inc. Announces Chief Executive Officer Changes
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022
Theralink Technologies Appoints Michael Vallone as Senior Director of Commercialization
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022
Theralink Technologies, Inc. Auditor Raises 'Going Concern' Doubt
Theralink Technologies, Inc. Appoints Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company
Theralink Technologies, Inc. Appoints Mattia Cremona as Its Director of Its Biopharma Laboratory
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
Theralink Technologies Expands Adoption of Its Precision Medicine Technology in the Biopharmaceutical Industry
Theralink Technologies, Inc. Announces Board Appointments
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THER Stock
  4. News Theralink Technologies, Inc.
  5. Other languages